Silicon Valley Bank: Fed says Vice Chair for Supervision to review what led to collapse
The Federal Reserve Board says Vice Chair for Supervision Michael S. Barr will lead a review of the supervision and regulation of Silicon Valley Bank.
Silicon Valley Bank collapse: GOP's Vivek Ramaswamy says more regulation would encourage ‘crony capitalism’
Republican 2024 presidential contender Vivek Ramaswamy believes that more regulation of the financial industry in the wake of the Silicon Valley Bank would encourage crony capitalism.
Feds hold auction for failed Silicon Valley Bank, move to protect uninsured depositors
Federal financial regulators are moving to reassure depositors at Silicon Valley Bank with a special backstop as they pursue the failed bank's sale through an auction.
Treasury, Federal Reserve, FDIC release joint statement mapping out approach to Silicon Valley Bank collapse
Treasury Department, Federal Reserve, and the FDIC issued a joint statement Sunday mapping out how regulators will handle the failure of Silicon Valley Bank.
China economic espionage 'top threat' to US commercial, military secrets
Intelligence community leaders rated China as the top threat to America's economic and technological competitiveness in congressional hearings on worldwide threats held last week.
Former Obama official worked at Silicon Valley Bank before collapse that rattled American economy
An official who served in the Treasury Department under former President Obama was also a board member of Silicon Valley Bank before its collapse last week.
Yellen says no bailout for Silicon Valley Bank: ‘We’re not going to do that again’
Treasury Secretary Janet Yellen said Sunday that federal government bailouts are not coming for Silicon Valley Bank, which collapsed last week.
US probe of dog breeder scrutinizes why USDA left thousands of beagles to suffer
USDA took no action against drug maker Envigo who had to forfeit 4,000 beagles after mistreating them. Envigo settled civil charges but Grand Jury explores legal options.
New drugs are coming to market at sky-high prices
To avoid government penalties for raising drug prices, pharmaceutical companies are releasing drugs at higher prices with hefty rebates to maintain profitability.
Wegovy, Ozempic: The barriers to accessing these weight loss drugs
Doctors tell FOX Business that there are a handful of barriers keeping people from being able to take Wegovy and Ozempic including insurance coverage, high cost and availability issues.
South Korea says US Chips Act subsidies have too many requirements
SK Group of South Korea has pledged a $15 billion U.S. investment that includes semiconductor research and development.
US challenges Mexico’s plan to phase out imports of corn from GMO seeds
During 2022, Mexico purchased nearly $5 billion worth of corn from the U.S., making it the second largest importer after China. US exports to Mexico are GMO based.
JetBlue, Spirit brace for Justice Department lawsuit to block airlines’ merger
JetBlue expects a lawsuit from the Justice Department over the $3.8 billion merger with Spirit Airlines; Spirit argues deal would save customers millions.
FDA to decide on full approval of Alzheimer's treatment Leqembi in early July
The FDA will decide on July 6 whether to grant full approval to the new Alzheimer's treatment Leqembi, Japanese drugmaker Eisai and its U.S. partner Biogen said.
Family sues Airbnb after toddler dies of fentanyl overdose in rental
The Lavenir family filed a wrongful death lawsuit against Airbnb, a rental owner, and the prior renter after their 19-month-old daughter died due to fentanyl exposure.
Washington offering drug offenders priority status for 'social equity' licenses to sell weed
The Washington State Liquor and Cannabis Board is offering available retail licenses to sell marijuana, prioritizing former offenders in the name of "social equity."
Economy, job market among nation’s most pressing issues, say concerned Americans
People in Austin, Texas, identified what they believed to be the most pressing issues facing America currently, with over half of people pointing to the economy
Investors pull around $6 billion out of Binance's stablecoin
Binance USD, Binance's stablecoin pegged to the US dollar has seen outflows equivalent to more than 1/3 its market cap as regulatory pressure scares investors away.
Congress investigates how pharma middlemen affect drug prices
House Republicans are investigating pharmacy-benefit managers, middlemen in drug price negotiations, over whether they create unnecessary costs for prescription drugs.
Huawei export licenses could be revoked by US
Huawei was previously placed on the US Commerce Department’s blacklist over concerns China could use the company’s telecommunications tech for spying.